173 related articles for article (PubMed ID: 6147145)
1. Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility.
Kerry R; Scrutton MC; Wallis RB
Biochem Pharmacol; 1984 Aug; 33(16):2615-22. PubMed ID: 6147145
[TBL] [Abstract][Full Text] [Related]
2. Influence of some beta blockers (pindolol, atenolol, timolol and metoprolol) on aggregation and arachidonic acid metabolism in human platelets.
Srivastava KC
Prostaglandins Leukot Med; 1987 Sep; 29(1):79-84. PubMed ID: 2890173
[TBL] [Abstract][Full Text] [Related]
3. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
Krishnamurthi S; Joseph S; Kakkar VV
Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers.
Gasser JA; Betterridge DJ
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976
[TBL] [Abstract][Full Text] [Related]
5. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
6. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
[TBL] [Abstract][Full Text] [Related]
7. Influence of propranolol, pindolol, practolol and talinolol on arachidonic acid (AA)- and U-46619-induced aggregation and on AA-induced thromboxane A2 formation in platelets.
Heinroth I; Block HU; Pönicke K; Förster W
Prostaglandins Leukot Med; 1983 Oct; 12(2):189-206. PubMed ID: 6139824
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation.
Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
Thromb Haemost; 1985 Aug; 54(2):480-4. PubMed ID: 2867620
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing the response of human blood platelets to analogues of ADP which may act as partial agonists at the ADP receptor.
Egan CM; Fisher AP; Scrutton MC
Eur J Biochem; 1979 Mar; 95(1):127-37. PubMed ID: 110586
[TBL] [Abstract][Full Text] [Related]
10. Effects of trifluoperazine on platelet activation.
Ardlie NG; Boatwright C; Garrett J; McGuiness JA
Thromb Res; 1985 Jun; 38(6):695-706. PubMed ID: 3161211
[TBL] [Abstract][Full Text] [Related]
11. Phenothiazine compounds enhance phentolamine effects on platelet aggregation and thromboxane B2 production.
Anfossi G; Trovati M; Mularoni E; Massucco P; Cavalot F; Mattiello L; Emanuelli G
Arch Int Pharmacodyn Ther; 1990; 307():142-61. PubMed ID: 1982777
[TBL] [Abstract][Full Text] [Related]
12. [The role of prostaglandins in the effect of beta-blockers on stimulated blood platelets].
Nosál' R; Jancinová V; Petríková M
Vnitr Lek; 1991 Mar; 37(3):261-7. PubMed ID: 1674390
[TBL] [Abstract][Full Text] [Related]
13. Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP.
Burns GB; Dodge JA
Agents Actions; 1984 Jan; 14(1):102-8. PubMed ID: 6322546
[TBL] [Abstract][Full Text] [Related]
14. Adrenaline infusion evokes increased thromboxane B2 production by platelets in healthy men: the effect of beta-adrenoceptor blockade.
Laustiola K; Kaukinen S; Seppälä E; Jokela T; Vapaatalo H
Eur J Clin Invest; 1986 Dec; 16(6):473-9. PubMed ID: 2881786
[TBL] [Abstract][Full Text] [Related]
15. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
16. Effects of three beta-blockers with different pharmacodynamic properties on platelet aggregation and platelet and plasma cyclic AMP.
Winther K; Trap-Jensen J
Eur J Clin Pharmacol; 1988; 35(1):17-20. PubMed ID: 2905989
[TBL] [Abstract][Full Text] [Related]
17. Alterations in lipid peroxidation of thrombin-stimulated rat platelets treated with beta-adrenoceptor blocking drugs.
Nosál R; Petríková M; Jancinová V
J Lipid Mediat; 1993 Oct; 8(2):121-32. PubMed ID: 7903565
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of collagen-induced platelet aggregation and adhesion by a pseudocyanide derivative of avicine isolated from Zanthoxylum integrifoliolum Merr.
Ko FN; Hsiao G; Chen IS; Wu SJ; Teng CM
Biochem Pharmacol; 1993 Oct; 46(7):1165-73. PubMed ID: 8216367
[TBL] [Abstract][Full Text] [Related]
19. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
[TBL] [Abstract][Full Text] [Related]
20. Regulatory role of cyclic adenosine 3',5'-monophosphate on the platelet cyclooxygenase and platelet function.
Fitzpatrick FA; Gorman RR
Biochim Biophys Acta; 1979 Jan; 582(1):44-58. PubMed ID: 216415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]